Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 03, 2020

SELL
$16.86 - $23.44 $33,720 - $46,880
-2,000 Reduced 16.67%
10,000 $232,000
Q4 2018

Jan 25, 2019

BUY
$30.43 - $56.65 $365,160 - $679,800
12,000 New
12,000 $394,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $231M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Supplemental Annuity Collective Trust Of Nj Portfolio

Follow Supplemental Annuity Collective Trust Of Nj and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Supplemental Annuity Collective Trust Of Nj, based on Form 13F filings with the SEC.

News

Stay updated on Supplemental Annuity Collective Trust Of Nj with notifications on news.